Community Blood Center
Michael Rogers has a wealth of experience in the blood banking industry. Michael started their career at US Cellular as a Sales Manager in 1993 and worked there until 2004. In 2005, Rogers joined the Community Blood Centers of South Florida, initially as a Collection Area Director and later as the Vice President of Operations. Michael held these positions until 2012 when they became the Senior Vice President at OneBlood, where they currently work.
Michael Rogers attended Florida State University from 1987 to 1989, during which they did not obtain a degree or specify a field of study. Michael later enrolled at the University of Florida from 1989 to 1991 and earned a Bachelor of Arts degree. The field of study for their degree was not mentioned.
This person is not in any offices
Community Blood Center
The Community Blood Center (CBC) began operation in September 1964. In 1964, the CBC served two Dayton area hospitals, and by 1965 it had expanded to serving the blood needs of all general hospitals in Dayton. Since 1967, CBC has grown to its present service area of 25 hospitals in 15 counties with a totally volunteer donor base. At least 325 pints of whole blood must be collected daily from volunteer donors to sufficiently meet patient transfusion needs. This year that need is projected to reach more than 70,000 units of blood products. All donated blood becomes part of the general blood supply. Each unit of blood is tested, typed and processed by the Dayton CBC laboratory, then distributed daily to the 24 area hospitals. In November 1986, CBC expanded operations and started the Dayton Regional Tissue Center. In 1994, the name was changed to Community Tissue Services (CTS) and there are now CTS branches in Indianapolis, Indiana; Fort Worth, Texas; Portland, Oregon; and Fresno, California, in addition to the Dayton headquarters. Since its beginning, CTS has doubled in size each year, and it now provides tissue for more than 2,000 hospital and physician clients across the nation. CBC is a 501(c) 3, not-for-profit, tax-exempt corporation. Operating income is derived from the charges made to the hospitals for blood and blood products, transfusions and for patient services and tests, as well as the distribution of tissue to hospitals and physicians.